Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy

被引:0
|
作者
Shemonti Hasan
Onilia Zorio
B. Mark Keegan
Brian G. Weinshenker
Eoin P. Flanagan
W. Oliver Tobin
Orhun H. Kantarci
Michel Toledano
Sean J. Pittock
Sebastian Lopez-Chiriboga
Anastasia Zekeridou
Cristina Valencia-Sanchez
机构
[1] Mayo Clinic Arizona,Department of Neurology
[2] Mayo Clinic,Department of Neurology
[3] University of Virginia,Department of Neurology
[4] Mayo Clinic,Department of Laboratory Medicine and Pathology
[5] Mayo Clinic,Department of Neurology
来源
Journal of Neurology | 2023年 / 270卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4707 / 4712
页数:5
相关论文
共 50 条
  • [31] Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment
    Dobosz, Paula
    Stepien, Maria
    Golke, Anna
    Dzieciatkowski, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [32] A Celiac Disease Phenotype After Checkpoint Inhibitor Exposure: An Example of Immune Dysregulation After Immunotherapy
    Arnouk, Joud
    Mathew, Don
    Nulton, Ethan
    Rachakonda, Vikrant
    ACG CASE REPORTS JOURNAL, 2019, 6 (08)
  • [33] Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
    Ma, Zehua
    Zhang, Weiwei
    Dong, Baijun
    Xin, Zhixiang
    Ji, Yiyi
    Su, Ruopeng
    Shen, Kai
    Pan, Jiahua
    Wang, Qi
    Xue, Wei
    THERANOSTICS, 2022, 12 (11): : 4965 - 4979
  • [34] Rectal Ulcer and Fistula Development in a Cancer Patient on Immune Checkpoint Inhibitor Immunotherapy: A Case Report
    Catinis, Christine
    Mittal, Nitish
    Aujla, Parvir
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1991 - S1991
  • [35] Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
    Xiao, Wei
    Ibrahim, Mohammed L.
    Redd, Priscilla S.
    Klement, John D.
    Lu, Chunwan
    Yang, Dafeng
    Savage, Natasha M.
    Liu, Kebin
    MOLECULAR CANCER RESEARCH, 2019, 17 (02) : 420 - 430
  • [36] Rectal Ulcer and Fistula Development in a Cancer Patient on Immune Checkpoint Inhibitor Immunotherapy: A Case Report
    Catinis, Christine
    Sarihan, Maya
    Aleem, Abdullah
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1630 - S1631
  • [37] Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
    Suresh, Karthik
    Psoter, Kevin J.
    Voong, Khinh Ranh
    Shankar, Bairavi
    Forde, Patrick M.
    Ettinger, David S.
    Marrone, Kristen A.
    Kelly, Ronan J.
    Hann, Christine L.
    Levy, Benjamin
    Feliciano, Josephine L.
    Brahmer, Julie R.
    Feller-Kopman, David
    Lerner, Andrew D.
    Lee, Hans
    Yarmus, Lonny
    Hales, Russell K.
    D'Alessio, Franco
    Danoff, Sonye K.
    Naidoo, Jarushka
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 494 - 502
  • [38] Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy
    Zekeridou, Anastasia
    Lennon, Vanda A.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (09) : 1865 - 1878
  • [39] Autoimmune Polyarthritis Induced by Cancer Immunotherapy With Checkpoint Inhibitor
    Quresh, Quretul
    Quinet, Robert
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (04) : 235 - 235
  • [40] Sclerosing mesenteritis following immune checkpoint inhibitor therapy
    Kuang, Andrew G. G.
    Sperling, Gabriel
    Liang, Tom Z. Z.
    Lu, Yang
    Tan, Dongfeng
    Bollin, Kathryn
    Johnson, Douglas B. B.
    Manzano, Joanna-Grace M.
    Shatila, Malek
    Thomas, Anusha S. S.
    Thompson, John A. A.
    Zhang, Hao Chi
    Wang, Yinghong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 9221 - 9227